Revolution Medicines, Inc.
RVMD
55 insider filings · Latest: Sep 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Nov 1 8:42 PM | J H GOLDSMITH & M A GOLDSMITH CO-TTEE JONATHAN GOLDSMITH REV TRU/A/D 8/16/2023 | Proposed Sale | 5,000 | $53.50 | $267.5K | — | View → |
| Nov 1, 2024 | Nov 1 8:42 PM | MARK A GOLDSMITH | Proposed Sale | 60,000 | $53.50 | $3.2M | — | View → |
| Oct 31, 2024 | Oct 31 8:30 PM | SUSHIL PATEL | Proposed Sale | 5,000 | $50.50 | $252.5K | — | View → |
| Oct 14, 2024 | Oct 15 12:03 PM | STEPHEN M. KELSEY | Proposed Sale | 16,666 | $50.48 | $841.3K | — | View → |
| Oct 11, 2024 | Oct 11 8:22 PM | MARK A GOLDSMITH | Proposed Sale | 30,000 | $49.50 | $1.5M | — | View → |
| Oct 11, 2024 | Oct 11 8:21 PM | JEFFREY TODD CISLINI | Proposed Sale | 6,000 | $49.50 | $297.0K | — | View → |
| Oct 11, 2024 | Oct 11 8:21 PM | JACK LEE ANDERS | Proposed Sale | 10,000 | $49.50 | $495.0K | — | View → |
| Oct 11, 2024 | Oct 11 8:21 PM | MARGARET A HORN | Proposed Sale | 50,000 | $49.50 | $2.5M | — | View → |
| Oct 8, 2024 | Oct 8 8:23 PM | BARBARA L WEBER | Proposed Sale | 5,200 | $47.34 | $246.2K | — | View → |
| Oct 1, 2024 | Oct 1 8:33 PM | MARK A GOLDSMITH | Proposed Sale | 10,000 | $45.35 | $453.5K | — | View → |
| Sep 16, 2024 | Sep 16 11:06 PM | Anders Jack | Proposed Sale | 1,832 | $42.12 | $77.2K | — | View → |
| Sep 16, 2024 | Sep 16 10:41 PM | Kelsey Stephen Michael | Proposed Sale | 4,601 | $42.12 | $193.8K | — | View → |
| Sep 16, 2024 | Sep 16 10:22 PM | Horn Margaret A | Proposed Sale | 4,271 | $42.12 | $179.9K | — | View → |
| Sep 16, 2024 | Sep 16 9:37 PM | Cislini Jeff | Proposed Sale | 1,433 | $42.12 | $60.4K | — | View → |
| Sep 16, 2024 | Sep 16 9:24 PM | Anders Jack | Proposed Sale | 1,832 | $42.12 | $77.2K | — | View → |
| Sep 16, 2024 | Sep 16 9:15 PM | GOLDSMITH MARK A | Proposed Sale | 11,561 | $42.12 | $486.9K | — | View → |
| Sep 13, 2024 | Sep 13 8:23 PM | STEPHEN M. KELSEY | Proposed Sale | 16,667 | $41.97 | $699.5K | — | View → |
← Previous
Page 8 of 8
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Apr 29 9:50 PM | Anthony ManciniChief Global Commercialization Officer | Option Exercise | 3,120 | $33.62 | 109,230(D) | View → |
| Apr 15, 2026 | Apr 17 11:26 PM | Mark A GoldsmithDirector, President and Chief Executive Officer | Option Exercise | 120,000 | $4.73 | 424,085(D) | View → |
| Mar 25, 2026 | Mar 27 12:04 AM | Anthony ManciniChief Global Commercialization Officer | Option Exercise | 37,450 | $33.62 | 112,350(D) | View → |
| Mar 1, 2026 | Mar 4 2:11 AM | Xiaolin WangEVP, Clinical Development | Grant/Award | 34,000 | $102.02 | 34,000(D) | View → |
| Mar 1, 2026 | Mar 4 2:10 AM | Lin WeiChief Medical Officer | Grant/Award | 34,000 | $102.02 | 34,000(D) | View → |
| Mar 1, 2026 | Mar 4 2:09 AM | Stephen Michael KelseyPresident, Research and Development | Grant/Award | 47,600 | $102.02 | 47,600(D) | View → |
| Mar 2, 2026 | Mar 4 2:09 AM | Mark A GoldsmithDirector, President and Chief Executive Officer | Option Exercise | 30,000 | $4.09 | 47,708(D) | View → |
| Mar 1, 2026 | Mar 4 2:09 AM | Mark A GoldsmithDirector, President and Chief Executive Officer | Grant/Award | 128,600 | $102.02 | 128,600(D) | View → |
| Mar 1, 2026 | Mar 4 2:08 AM | Margaret A HornChief Operating Officer | Grant/Award | 47,600 | $102.02 | 47,600(D) | View → |
| Mar 1, 2026 | Mar 4 2:08 AM | Jeff CisliniGeneral Counsel | Grant/Award | 32,500 | $102.02 | 32,500(D) | View → |
| Mar 1, 2026 | Mar 4 2:07 AM | Jack AndersChief Financial Officer | Grant/Award | 45,400 | $102.02 | 45,400(D) | View → |
| Feb 6, 2026 | Feb 10 10:30 PM | Mark A GoldsmithDirector, President and Chief Executive Officer | Option Exercise | 24,010 | $0.54 | 144,493(D) | View → |
← Previous
Page 2 of 2